Odyssey Therapeutics, Inc. (NASDAQ:ODTX) Financings
Financings
| Raise | Date |
|---|---|
| Public offering of common stock Closed: US$18 a share Use of proceeds: Advance OD-001 and the broader portfolio, including SLC15A4 inhibitor OD-002 | Jun 17, 2026 |
| Private placement of common stock Closed: US$18 a share | Jun 17, 2026 |